16th Annual European Congress of Rheumatology - European League Against Rheumatism
 
                                    Programme du congrès
Tocilizumab as compared to abatacept in those with prior exposure to anti-TNF_agents
 
 
                                                                    
                                                                - Date : 10/06/2015
-  3  
                                                                                   0
Secukinumab significantly improves signs and symptoms of active ankylosing spondylitis
 
 
                                                                    
                                                                - Date : 10/06/2015
-  2  
                                                                                   0
Apremilast associated with long term (104week) improvements in enthesitis and dactylitis
 
 
                                                                    
                                                                - Date : 10/06/2015
-  1  
                                                                                   0
Sélection de congrès
Congrès Annuel de l'American College of Rheumatology - ACR Convergence 2025
 
                                     
                                    - Date : 24/10/2025
- 
                                            
                                            8937                                                 0
 
 
                                                                     
 
                                                                     
 
                                                                     
 
                                                                     
 
                                                                     
 
                                                                     
 
                                                                     
 
                                                                     
 
                                                                     
 
                                                                     
 
                                                                     
 
                                                                     
 
                                                                     
 
                                                                     
 
                                                                     
 
                                                                     
                                      
                                      
                                     